» Articles » PMID: 33502086

Causal Integration of Multi-omics Data with Prior Knowledge to Generate Mechanistic Hypotheses

Abstract

Multi-omics datasets can provide molecular insights beyond the sum of individual omics. Various tools have been recently developed to integrate such datasets, but there are limited strategies to systematically extract mechanistic hypotheses from them. Here, we present COSMOS (Causal Oriented Search of Multi-Omics Space), a method that integrates phosphoproteomics, transcriptomics, and metabolomics datasets. COSMOS combines extensive prior knowledge of signaling, metabolic, and gene regulatory networks with computational methods to estimate activities of transcription factors and kinases as well as network-level causal reasoning. COSMOS provides mechanistic hypotheses for experimental observations across multi-omics datasets. We applied COSMOS to a dataset comprising transcriptomics, phosphoproteomics, and metabolomics data from healthy and cancerous tissue from eleven clear cell renal cell carcinoma (ccRCC) patients. COSMOS was able to capture relevant crosstalks within and between multiple omics layers, such as known ccRCC drug targets. We expect that our freely available method will be broadly useful to extract mechanistic insights from multi-omics studies.

Citing Articles

Integrating multi-omics data to reveal the host-microbiota interactome in inflammatory bowel disease.

Su F, Su M, Wei W, Wu J, Chen L, Sun X Gut Microbes. 2025; 17(1):2476570.

PMID: 40063366 PMC: 11901428. DOI: 10.1080/19490976.2025.2476570.


Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions.

Sabit H, Arneth B, Altrawy A, Ghazy A, Abdelazeem R, Adel A Biomedicines. 2025; 13(2).

PMID: 40002898 PMC: 11852909. DOI: 10.3390/biomedicines13020485.


Towards an interpretable deep learning model of cancer.

Nilsson A, Meimetis N, Lauffenburger D NPJ Precis Oncol. 2025; 9(1):46.

PMID: 39948231 PMC: 11825879. DOI: 10.1038/s41698-025-00822-y.


Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions.

Bumbaca B, Huggins J, Birtwistle M, Gallo J NPJ Syst Biol Appl. 2025; 11(1):14.

PMID: 39893170 PMC: 11787326. DOI: 10.1038/s41540-025-00493-2.


Challenges and opportunities for digital twins in precision medicine from a complex systems perspective.

De Domenico M, Allegri L, Caldarelli G, dAndrea V, Di Camillo B, Rocha L NPJ Digit Med. 2025; 8(1):37.

PMID: 39825012 PMC: 11742446. DOI: 10.1038/s41746-024-01402-3.


References
1.
Melas I, Sakellaropoulos T, Iorio F, Alexopoulos L, Loh W, Lauffenburger D . Identification of drug-specific pathways based on gene expression data: application to drug induced lung injury. Integr Biol (Camb). 2015; 7(8):904-20. DOI: 10.1039/c4ib00294f. View

2.
Singh D, Arora R, Kaur P, Singh B, Mannan R, Arora S . Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer. Cell Biosci. 2017; 7:62. PMC: 5683220. DOI: 10.1186/s13578-017-0190-2. View

3.
Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

4.
Zhang J, Zhang F, Hong C, Giuliano A, Cui X, Zhou G . Critical protein GAPDH and its regulatory mechanisms in cancer cells. Cancer Biol Med. 2015; 12(1):10-22. PMC: 4383849. DOI: 10.7497/j.issn.2095-3941.2014.0019. View

5.
Bailey S, Smith A, Kardos J, Wobker S, Wilson H, Krishnan B . MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma. Nat Commun. 2017; 8:15770. PMC: 5472759. DOI: 10.1038/ncomms15770. View